期刊文献+

RE-1元件辅助抑制因子对骨关节炎软骨细胞分化的调控作用 被引量:2

Modulatory effects of CoREST on osteoarthritic chondrocytes differentiation
原文传递
导出
摘要 目的观察RE-1元件辅助抑制因子(CoREST)在骨关节炎(OA)软骨细胞中的差异表达并探讨CoREST对OA软骨细胞分化的调控作用。方法取材接受膝关节表面置换的OA患者和正常对照组软骨并提取软骨细胞总蛋白,以Western blot对比CoREST在OA(n=8)和正常软骨(n=8)细胞中表达水平的差异。培养正常原代软骨细胞,采用针对CoREST设计的敲除siRNACoREST的表达至OA相当水平。应用Realtime聚合酶链反应(PCR)技术监测敲除CoREST前后软骨细胞(n=6)表型基因(I型胶原、Ⅱ型胶原、aggrecan和X型胶原)表达水平的变化。结果CoREST表达水平较正常软骨细胞下降69.5%(P〈0.01)。将正常软骨细胞中的CoREST表达knock—down 64.8%后,软骨细胞终末分化表型基因X型胶原的表达水平升高40.0%(P〈0.05),而正常分化表型Ⅱ型胶原和aggrecan的基因表达水平分别降低71.4%(P〈0.01)和57.6%(P〈0.01)。结论CoREST在OA软骨细胞中表达下降,诱发软骨细胞表型基因表达变化,提示CoREST参与了OA软骨细胞分化的调控。 Objective To compare the differential expression of RE-1 silencing transcription factor (REST) corepressor (CoREST) in normal and osteoarthritic chondrocytes and investigate the role of CoR- EST in regulating osteoarthritic chondrocyte differentiation. Methods Osteoarthritic knee cartilage samples were obtained from patients with osteoarthritis undergoing total knee replacement and normal controls. Chonrocytes were isolated and total protein was extracted for Western blotting analysis to compare the differ- ential expression of CoREST between normal controls (n = 8) and osteoarthritic (n = 8) chondrocytes. Pri- marily cultured normal chondrocytes ( n = 6) were treated with specific siRNA to mimic CoREST repression in osteoarthritis. Realtime polymerase chain reaction (PCR) was used to compare the differential expression of chondrocyte phynotypic genes (collagen I, collagen Ⅱ, collagen X and aggrecan) before and after CoREST knock-down. Results CoREST expression level was down-regulated by 69.5% (P 〈 0. 01 ) in osteoarthritic chondrocytes in contrast to that of normal controls. In response to CoREST knock-down by 64. 8% (P 〈0. 01 ) in the primarily cultured chondrocytes, the gene expression level of the chondrocyte terminal differentiation marker gene, collagen X was up-regulated by 40. 0% (P 〈 0. 05) , whereas the differentiation phenotypic genes, collagen Ⅱ and aggrecan were down-regulated by 71.4% (P 〈 0. 01 ) and 57.6% (P 〈 0. 01 ), respectively. Conclusion CoREST down-regulation triggered the expression regulation of phenotypic genes towards terminal differentiation, which suggested CoREST is involved in the differentiation status modulation of osteoarthritic chodnrocytes.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第8期1375-1377,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:广东省医学科研基金资助项目(A2010362)
关键词 骨关节炎 软骨细胞 分化 RE-1元件辅助抑制因子 表型 Osteoarthritis Chondrocyte Differentiation REST corepressor (CoREST) Phenotype
  • 相关文献

参考文献7

  • 1Andres ME,Burger C,Peral-Rubio MJ,et al.CoREST:a functional corepressor required for regulation of neural-specific gene expression.Proc Natl Acad Sci USA,1999,96:9873-9878.
  • 2Jones FS,Meech R.Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues.Bioessays,1999,21:372-376.
  • 3Aigner T,McKenna L.Molecular pathology and pathobiology of osteoarthritic cartilage.Cell Mol Life Sci,2002,59:5-18.
  • 4肖军,史占军,吴志宏,梁锦前,赵赞栋,周亚鹏,兰天,邱贵兴.膝关节骨关节炎软骨细胞差异表达蛋白的研究[J].中华医学杂志,2010,90(45):3193-3197. 被引量:2
  • 5Abrajano JJ,Qureshi IA,Gokhan S,et al.Differential deployment of REST and CoREST promotes glial subtype specification and oligodeudrocyte lineage maturation.PLoS One,2009,4:7665.
  • 6Martin I,Jakob M,Schafer D,et al.Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints.Osteoarthritis Cartilage,2001,9:112-118.
  • 7Ballas N,Battaglioli E,Atouf F,et al.Regulation of neuronal traits by a novel transcriptional complex.Neuron,2001,31:353-365.

二级参考文献13

  • 1Aigner T,McKenna L.Molecular pathology and pathobiology of osteoarthritic cartilage.Cell Mol Life Sci,2002,59:5-18.
  • 2Ruiz-Romero C,Lopez-Armada MJ,Blanco FJ.Proteomic characterization of human normal articular chondrocytes:a novel tool for the study of osteoarthritis and other rheumatic diseases.Proteomics,2005,5:3048-3059.
  • 3Ruiz-Romero C,Carreira V,Rego I,et al.Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis.Proteomics,2008,8:495-507.
  • 4Outerbridge RE.The etiology of chondromalacia patellae.J Bone Joint Surg Br,1961,43-B:752-757.
  • 5van der Sluijs JA,Geesink RG,van der Linden AJ,et al.The reliability of the Mankin score for osteoarthritis.J Orthop Res,1992,10:58-61.
  • 6Zhang J,Kang B,Tan X,et al.Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions:MAWBP could be a new protein candidate involved in gastric cancer.J Proteome Res,2007,6:4423-4432.
  • 7Capin-Gutierrez N,Talamas-Rohana P,Gonzalez-Robles A,et al.Cytoskeleton disruption in chondrocytes from a rat osteoarthrosic (OA) -induced model:its potential role in OA pathogenesis.Histol Histopathol,2004,19:1125-1132.
  • 8Pullig O,Weseloh G,Swoboda B.Expression of type Ⅵ collagen in normal and osteoarthritic human cartilage.Osteoarthritis Cartilage,1999,7:191-202.
  • 9Eid K,Thomhill TS,Glowacki J.Chondrocyte gene expression in osteoarthritis:Correlation with disease severity.J Orthop Res,2006,24:1062-1068.
  • 10Pak JH,Manevich Y,Kim HS,et al.An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells.J Biol Chem,2002,277:49927-49934.

共引文献1

同被引文献12

  • 1Scarpellini M, Lurati A, Vignati G, et al. Biomarkers, type Ⅱ colla- gen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the "Magenta osteoarthritis study". J Orthop Traumatol,:2008,9 : 81 - 87.
  • 2Studelska DR, Mandik-Nayak L, Zhou X, et al. High affinity glyco- saminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis. Biol Chem, 2009,284 : 2354- 2362.
  • 3Shukla/diD, Sharma SK. Clostridium botulinum : a bug with beauty and weapon. Crit Rev Microbiol,2005,31:11-18.
  • 4Liu HT, Tsai SK, Kao MC, et al. Botulinum toxin A relieved neuro- pathic pain in a case of post-herpetic neuralgia. Pain Med, 2006,7 : 89-91.
  • 5Bach-Rojecky L, Relja M, Lackovicff Z. Botulinum toxin type A in ex- perimemal neumpathic pain. J Neural Transm ,2005,112:215-219.
  • 6Lim S J, Park H J, Lee SH, et al. Ganglion impar block with botulinum toxin type a for chronic perineal pain-a case report. Korean Pain, 2010.23:65-69.
  • 7Bach-Rojecky L, Salkovid-Petrisic M, Lackoviff Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropa- thy:bilateral effect after unilateral injection. Eur J Pharmacol,2010, 633 : 10-14.
  • 8Keith F, John C. Targeted secretion inhibitors-innovative protein ther- apeutics. Toxins (Basel) ,2010,2:2795-2815.
  • 9I~harkar S, Ambady P, Venkatesh Y, et al. Intramuscular botulinum toxin in complex regional pain syndrome:case series and literature re- view. Pain Physician ,2011,14:419-424.
  • 10Santamato A, Panza F, Di Venere D. Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism : a case re- port. J Chiropr Med ,2010,9 : 132-137.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部